BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16375647)

  • 1. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Pollera CF; Nelli F
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
    Rosenberg JE
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1729-36. PubMed ID: 18062747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Shimabukuro T; Nakamura K; Uchiyama K; Tei Y; Aoki A; Naito K
    Hinyokika Kiyo; 2006 Feb; 52(2):99-105. PubMed ID: 16541762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.
    Pectasides D; Pectasides M; Nikolaou M
    Eur Urol; 2005 Jul; 48(1):60-7; discussion 67-8. PubMed ID: 15967253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?].
    Housset M; Dufour B; Durdux C; Chrétien Y; Méjean A; Baillet F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():67s-72s. PubMed ID: 9749082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in first- and second-line chemotherapy for transitional cell, squamous cell and adenocarcinoma of the bladder.
    De Santis M; Bachner M
    Curr Opin Urol; 2007 Sep; 17(5):363-8. PubMed ID: 17762632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
    Milowsky MI; Stadler WM; Bajorin DF
    BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
    Li Q; Xu X; Liu J
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):308-9. PubMed ID: 10920993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    Calabrò F; Sternberg CN
    Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?
    Mazhar D; Ali N; Ngan S
    Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in muscle-invasive bladder cancer: ready for prime time?
    Pouessel D; Mongiat-Artus P; Culine S
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):288-94. PubMed ID: 23022113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of locally advanced bladder cancer: early vs deferred chemotherapy.
    Syed S; Weiss GR
    World J Urol; 2002 Aug; 20(3):175-82. PubMed ID: 12196901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].
    Pollera CF
    Suppl Tumori; 2004; 3(4):S59-61. PubMed ID: 15206215
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preoperative or neoadjuvant chemotherapy. Our experience with 37 patients].
    Escudero Barrilero A; Fernández E; Crespo C
    Arch Esp Urol; 1991 May; 44(4):379-92. PubMed ID: 2064440
    [No Abstract]   [Full Text] [Related]  

  • 17. Urothelial cancers: using biology to improve outcomes.
    Pezaro C; Liew MS; Davis ID
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):87-98. PubMed ID: 22149435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
    Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
    Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in invasive bladder cancer.
    Bamias A; Dimopoulos MA
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):993-1000. PubMed ID: 16336090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy for advanced bladder cancer: update and controversies.
    Garcia JA; Dreicer R
    J Clin Oncol; 2006 Dec; 24(35):5545-51. PubMed ID: 17158540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.